The Peanut Institute Report issue

Foundation Phase 1 Phase 2

Organization Overview

First Clinical Trial
2009
NCT01173042
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

The Peanut Institute

Active Ingredients

Drugs in Phase 2 Trials (1)

peanut (2 trials)

Drugs in Phase 1 Trials (1)

glucose (1 trial)

Drugs in Other Trials (1)

peanut protein (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cardiovascular Diseases (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 5
  • # of Trial APIs: 3